Results 81 to 90 of about 119,526 (169)

Emerging treatment options for the management of pemphigus vulgaris

, 2018
Khalaf Kridin Department of Dermatology, Rambam Health Care Campus, Haifa, Israel Abstract: Pemphigus vulgaris (PV) is a life-threatening disease belonging to the pemphigus group of autoimmune intra-epidermal bullous diseases of the skin and mucosae ...
Kridin K
core  

Dipeptidyl Peptidase‐4 Inhibitor Use and Risk of Pemphigus Vulgaris and Foliaceus: A Retrospective Cohort Study Using Databases of the Korea National Health Insurance Claims and the National Health Screening Examination

The Journal of Dermatology, Volume 53, Issue 10, Page 1429-1438, October 2026.
ABSTRACT Although population‐based studies have reported an increased risk of bullous pemphigoid and pemphigus associated with dipeptidyl peptidase‐4 (DPP‐4) inhibitors, there is limited, well‐designed epidemiological evidence for pemphigus vulgaris (PV), which has only been supported by case reports thus far.
Jaein Lee, Jae Hyun Bae, Seokyung Hahn
wiley   +1 more source

Pemphigus vulgaris on the trunk

, 1997
Pemphigus vulgaris on the ...
Bezzant, John L.
core  

Pemphigus vulgaris and koebner phenomenon

, 2019
Pemphigus vulgaris is a rare disease characterized by loose bullae and erosions in the skin and mucous membranes. Koebner phenomenon is defined as the occurrence of new lesions that are characteristic of the disease at the site of trauma in normal ...
Hulya Nazik, Esra Aslan Koyuncu, Mehmet Kamil Mulayim, Perihan Ozturk   +3 more
core   +1 more source

Darier disease—A review highlighting new insights from the Darier Disease International Task Force

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 10, Page 1626-1647, October 2026.
This review provides a global, clinically focused overview of DD, detailing cutaneous and extracutaneous manifestations, disease classification and severity scoring. It emphasizes early recognition, multidisciplinary management and practical guidance for dermatologists to apply evidence‐based care in diverse skin phototypes. Abstract Darier disease (DD)
Sofia Labbouz, Alain Hovnanian, Grace Xiong, Dedee Frances Murrell, Simon M. Mueller, Khaled Ezzedine, Nessa Aghazadeh Mohandesi, Ahmed Salem Aldhaheri, Nissim Asayag, Eulalia Baselga, Chen Nadler, Keith Choate, Chia‐Yu Chu, John Robert Edminister, Emmanuella Guenova, Melis Gönülal, Antoni Gostynski, Ankan Gupta, Lalit Kumar Gupta, Juliette Mazereeuw‐Hautier, Wolfram Hoetzenecker, Peter Itin, Marek Jankowski, Akiharu Kubo, Haur Yueh Lee, Julia Scott Lehman, Anfisa Lepekhova, Márta Medvecz, Jemima E. Mellerio, Verena Moosbrugger‐Martinz, Amy S. Paller, Dóra Plázár, Amadeu José Rodrigues Queiróz, Josep Riera‐Monroig, Ralph Rosa, Matthias Schmuth, Maella Severino Freire, Itzhak Shabat, Jonathan Shapiro, Cory L. Simpson, Diego Soto‐García, Alexander J. Stratigos, Gianluca Abel Tadini, Takuya Takeichi, Kaushal K. Verma, Jakob D. Wikström, Alexander Zink, Michael Ziv, Alexander Navarini, Roni Pircha Dodiuk‐Gad   +49 more
wiley   +1 more source

Koebner phenomenon: pemphigus vulgaris following Mohs micrographic surgery. [PDF]

, 2019
Koebnerization of pemphigus vulgaris (PV) is an infrequently reported reaction. We present a 65-year-old man with Koebnerized pemphigus vulgaris after Mohs microscopic surgery for a basal cell carcinoma.
Sahu, Joya, Hattier, Georgette, Beggs, Sarah, Trufant, Joshua, Jones, Elizabeth   +4 more
core   +2 more sources

Efficacy of Repeated Courses of Rituximab as Treatment for Pemphigus Vulgaris

Acta Dermato-Venereologica, 2020
Rituximab targets the B-lymphocyte antigen CD20, providing pemphigus vulgaris patients with long-term remissions. However, the effects of repeated courses have not yet been established.
Sharon Baum, Tal Raviv, Sarit Gilboa, Felix Pavlotsky, Aviv Barzilai   +4 more
doaj   +1 more source

What Matters Most: A Case of Pemphigus Vulgaris in a Nonagenarian Physician

Journal of the American Geriatrics Society, EarlyView.
Svetlana Bagdasarov, Loma Dave, Alan Sang, Lisa Zhou, Billie Fyfe‐Kirschner, Ying Guo, Ibiyonu Lawrence   +6 more
wiley   +1 more source

Dermatologic Adverse Effects of Protein Supplements, Anabolic Performance Enhancers, and Other Performance Enhancers

Journal of Cosmetic Dermatology, Volume 25, Issue 10, October 2026.
ABSTRACT Background The prevalence of consumption of sports supplements and performance enhancers has increased among the general population. While these products are intended to improve muscle growth, endurance, and performance, several dermatologic effects have been reported.
Firas F. Haddad, Lina Abdullah, Mazen Kurban, Pierre Abi Akl, Ossama Abbas   +4 more
wiley   +1 more source

Low‐Level of BP180 and BP230 Autoantibody Reactivity in Oral Lichen Planus Does Not Predict Early Lichen Planus Pemphigoides

Oral Diseases, EarlyView.
Gabusi Andrea, Bardazzi Federico, Filippi Federica, Misciali Cosimo, La Placa Michelangelo, Clarizio Giacomo, Rossi Roberto, Gissi Davide   +7 more
wiley   +1 more source